In December 2006, SRI announced the establishment of a new multi-divisional facility in the Shenandoah Valley of Virginia. It is expected to become a self- sustaining, 100-person operation generating more than $20 million in revenues within 7 years. SRI-SV and its first group, the Center for Advanced Drug Research (CADRE), began operating on January 2, 2007.
SRI-SV has been made possible by Virginia commitments that total $22 million in funding ($15 million of which has been approved) for expenses over 4 to 7 years, plus a new facility to be built by the County of Rockingham. SRI-SV staff will be located at JMU temporarily, until the new building is ready to be occupied in 2009.
CADRE (The Center for Advanced Drug Research) will focus on the practical applications of proteomics-driven systems biology, a core of modern biosciences, to create new diagnostics, therapeutics, and vaccines for infectious disease and biodefense.
Nancy Adelman and her team in the Policy Division in SRI’s Arlington office have initiated a research effort, also in collaboration with JMU, to establish an education research group at SRI-SV.
Source: SRI Alumni Association Newsletter, 2007
SRI TImeline
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment